Inflammation News and Research

RSS

Research on naked mole-rats could pave way for new human pain therapies

In injuries and inflammation, naked mole-rats do not develop normal hypersensitivity to temperature stimuli.

12 Oct 2016

Common food-poisoning bacteria linked to increased risk of Crohn's disease

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

7 Oct 2016

UT Southwestern researchers discover protein that leads to brain cell death during stroke

One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report. This finding could ultimately lead to new ways to protect against brain damage.

7 Oct 2016

Study explores antimicrobial and antiinflammatory activities of bovine colostrum

Colostrum is a thick, sticky, yellowish mammary secretion that all mammals provide to their newborns during the first 24-48 hours after delivery.

7 Oct 2016

Researchers underscore how oxidative stress and inflammation may contribute to risk of schizophrenia

Schizophrenia is a devastating mental illness consisting of delusions, hallucinations or disorganized thoughts, afflicting about 1% of the population with onset typically in late adolescence.

7 Oct 2016

Researchers to investigate similarities between Crohn's and Johne's disease that affects cattle

Researchers still have a lot to learn about Crohn's disease, a chronic form of inflammatory bowel disorder that affects as many as 700,000 Americans.

6 Oct 2016

New non-invasive method could improve diagnosis of severe liver disease

A new non-invasive method of predicting the risk of developing a severe form of liver disease could ensure patients receive early and potentially life-saving medical intervention before irreversible damage is done.

6 Oct 2016

Researchers uncover potential role of gut bacteria in neurodegeneration

Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are all characterized by clumped, misfolded proteins and inflammation in the brain. In more than 90 percent of cases, physicians and scientists do not know what causes these processes to occur.

6 Oct 2016

Hard-to-control asthma in children has significant baseline features, study finds

Bronchodilator responsiveness, nasal inflammation and allergy were among the most significant baseline features that distinguished hard-to-control asthma in inner-city children and adolescents.

6 Oct 2016

New awards to explore role of glymphatic system in small vessel disease and trauma

More than $4.5 million in new grants to the lab of University of Rochester Medical Center scientist Maiken Nedergaard, M.D., D.M.Sc., underscore the important role the brain's waste disposal system may play in a range of neurological disorders.

6 Oct 2016

Scientists reveal molecular elements that bridge anxiety and metabolism

Metabolic and anxiety-related disorders both pose a significant healthcare burden, and are in the spotlight of contemporary research and therapeutic efforts. Although intuitively we assume that these two phenomena overlap, the link has not been proven scientifically.

5 Oct 2016

Some children with asthma may need different treatment approach, study finds

A new study by Henry Ford Health System in collaboration with eight other health systems in large U.S. cities, has identified a group of children with asthma that may require a different treatment approach.

5 Oct 2016

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

In the past vitamin D was just thought to be important in regulating calcium homeostasis and bone health as vitamin D deficiency is best known for causing rickets in children and osteomalacia in adults.

4 Oct 2016

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

4 Oct 2016

Researchers discover gene region that raises risk of middle ear infections in children

Researchers have discovered a gene region that raises the risk a child will have a middle ear infection, known to doctors as acute otitis media (AOM)—and known to parents as one reason for a screaming, unhappy preschooler.

4 Oct 2016

ACMSD enzyme could become key target for new drugs aimed at preventing suicide

An enzyme called ACMSD—part of a chain of biochemical reactions called the kynurenine pathway, activated by inflammation—could become an important target for new drugs aimed at preventing suicide.

3 Oct 2016

New portable adhesive patch drives small electrical current to promote wound healing

Good news for the millions of people who suffer from skin wounds that won't heal. A team of researchers at The Ohio State University has brought a potentially transformative solution to the problem by creating a portable adhesive patch that drives a continuous, small electrical current to stimulate healing and reduce the risk of infection.

30 Sep 2016

Research findings provide new clues to treat metabolic diseases

When people are deprived of food, a number of biological mechanisms are set in motion to adapt the body's metabolism to the conditions of scarcity.

30 Sep 2016

Researchers uncover key factor for promoting wound healing after corneal injuries

In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this happens remained a mystery — until now.

29 Sep 2016

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease.

29 Sep 2016

Inflammation News and Research

Research on naked mole-rats could pave way for new human pain therapies

Common food-poisoning bacteria linked to increased risk of Crohn's disease

UT Southwestern researchers discover protein that leads to brain cell death during stroke

Study explores antimicrobial and antiinflammatory activities of bovine colostrum

Researchers underscore how oxidative stress and inflammation may contribute to risk of schizophrenia

Researchers to investigate similarities between Crohn's and Johne's disease that affects cattle

New non-invasive method could improve diagnosis of severe liver disease

Researchers uncover potential role of gut bacteria in neurodegeneration

Hard-to-control asthma in children has significant baseline features, study finds

New awards to explore role of glymphatic system in small vessel disease and trauma

Scientists reveal molecular elements that bridge anxiety and metabolism

Some children with asthma may need different treatment approach, study finds

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers discover gene region that raises risk of middle ear infections in children

ACMSD enzyme could become key target for new drugs aimed at preventing suicide

New portable adhesive patch drives small electrical current to promote wound healing

Research findings provide new clues to treat metabolic diseases

Researchers uncover key factor for promoting wound healing after corneal injuries

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News